Femoral osteomyelitis due to Aspergillus nidulans in a patient with chronic granulomatous disease

Infection

Volumn 31, Issue 2, 2003, Pages 121-124

  Dotis, J ^a   Panagopoulou, P ^a   Filioti, J ^a   Winn, R ^a   Toptsis, C ^a   Panteliadis, C ^a   Roilides, E ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFTRIAXONE; CEFUROXIME; CLOXACILLIN; FUNGAL DNA; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; TEICOPLANIN;

ADOLESCENT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS NIDULANS; BONE RADIOGRAPHY; CASE REPORT; DEBRIDEMENT; DRUG BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMUR; GRANULOMATOSIS; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; TREATMENT OUTCOME;

ADOLESCENT; AMPHOTERICIN B; ASPERGILLOSIS; ASPERGILLUS NIDULANS; FEMUR; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; MALE; OSTEOMYELITIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037361113     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-002-2167-1     Document Type: Article

References (26)

1. Segal B, Leto T, Gallin J, Malech H, Holland S: Genetic, biochemical and clinical features of chronic granulomatous disease. Medicine 2000; 79: 170-200.
2. Winkelstein JA, Marino MC, Johnston RB, Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Ouie P, Buckley R H, Foster CB, Chanock SJ, Dickler H: Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine 2000; 79: 155-169.
3. Segal B, DeCarlo E, Kwon-Chung K, Malech H, Gallin J, Holland S: Apergillus nidulans infection in chronic granulomatous disease. Medicine 1998; 77: 1659-1665.
4. Johnston RB Jr: Clinical aspects of chronic granulomatous disease. Curr Opin Hematol 2000; 8: 17-22.
5. Redmond A, Carre IJ, Biggart JD, Mackenzie DWR: Aspergillosis (Aspergillus nidulans) involving bone. J Pathol Bacteriol 1965; 89: 391-395.
6. Bujak JS, Kwon-Chung KJ, Chusid MJ: Osteomyelitis and pneumonia in a boy with chronic granulomatous disease of childhood caused by a mutant strain of Aspergillus nidulans. Am J Clin Pathol 1974; 61: 361-367.
7. Altman AR: Thoracic wall invasion secondary to pulmonary aspergillosis: a complication of chronic granulomatous disease. Am J Roentgenol 1977; 129: 140-142.
8. Neijens HJ, Frenkel J, de Muinck Keizer-Schrama SM, Dzoljic-Danilovic G, Meradji M, van Dongen JJ: Invasive aspergillus infection in chronic granulomatous disease: treatment with itraconazole. J Pediatr 1989; 115: 1016-1019.
9. Sponseller PD, Malech HL, McCarthy EF Jr, Horowitz SF, Jaffe G, Gallin JI: Skeletal involvement in children who have chronic granulomatous disease. J Bone Joint Surg Am 1991; 73: 37-51.
10. Nake A, Kerkmann ML, Blaschke-Hellmessen R, Henker J, Schwarze R: Invasive aspergillosis in a child with chronic granulomatous disease: a try with liposomal bound amphotericin-B. Padiatr Grenzgeb 1994; 33: 109-115.
11. Kim M, Shin JH, Suh SP, Ryang DW, Park CS, Kim C, Kook H, Kim J: Aspergillus nidulans infection in a patient with chronic granulomatous disease. J Korean Med Sci 1997; 12: 244-248.
12. Ozsahin H, von Planta M, Muller I, Steinert HC, Nadal D, Lauener R, Tuchschmid P, Willi UV, Ozsahin M, Crompton NE, Seger RA: Successful treatment of invasive aspergillosis in chronic granulomatous disease by bone marrow transplantation, granulocyte colony-stimulating factor-mobilized granulocytes, and liposomal amphotericin-B. Blood 1998; 92: 2719-2724.
13. White CJ, Kwon-Chung KJ, Gallin JI: Chronic granulomatous disease of childhood. An unusual case of infection with Aspergillus nidulans var. echinulatus. Am J Clin Pathol 1988; 90: 312-316.
14. Verweij PE, Weemaes CM, Curfs JH, Bretagne S, Meis JF: Failure to detect circulating Aspergillus markers in a patient with chronic granulomatous disease and invasive aspergillosis. J Clin Microbiol 2000; 38: 3900-3901.
15. Yamakami Y, Hashimoto A, Tokimatsou I, Nasu M: PCR detection of DNA specific for Aspergillus species in serum of patients with invasive aspergillosis. J Clin Mirobiol 1996; 34: 2464-2468.
16. Yamakami Y, Hashimoto A, Yamagata E, Kamberi P, Karashima R, Nagai H, Nasu M: Evaluation of PCR detection of DNA specific for Aspergillus species in sera of patients with various forms of pulmonary aspergillosis. J Clin Mirobiol 1998; 36: 3619-3623.
17. National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi; Proposed Standard M38-P. National Committee for Clinical Laboratory Standards, Villanova, Pa. 1998.
18. Cohen MS, Isturiz RE, Malech HL, Root RK, Wilfert CM, Gutman L, Buckley RH: Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med 1981; 71: 59-66.
19. Denning DW: Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-803.
20. Kwon-Chung K, Bennett JE: In: Lea and Febiger (eds): Medical Mycology, Malvern, Pa, 1992, pp 201-247.
21. Casson DH, Riordan FA, Ladusens EJ: Aspergillus endocarditis in chronic granulomatous disease. Acta Paediatr 1996; 85: 758-759.
22. Tsumura N, Akasu Y, Yamane H, Ikezawa S, Hirata T, Oda K, Sakata Y, Shirahama M, Inoue A, Kato H:Aspergillus osteomyelitis in a child who has p67-phox-deficient chronic granulomatous disease. Kurume Med J 1999; 46: 87-90.
23. van't Hek LG, Verweiji PE, Weemaes CM, van Dalen R, Yntema J-B, Meis JF: Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease. Am J Respir Crit Care Med 1998; 157: 1694-1696.
24. Maertens J,Verhaegen J, Lagrou K, van Eldere J, Boogaerts M: Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001; 97: 1604-1610.
25. Roilides E, Uhlig K, Venzon D, Pizzo PA, Walsh TJ: Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon. Infect Immun 1993; 61: 1185-1193.
26. Roilides E, Uhlig K,Venzon D, Pizzo PA, Walsh TJ:. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and interferon-γ. Infect Immun 1993; 61: 4870-4877.